Immage Biotherapeutics Corp.
IMMG
$0.00
$0.000.00%
OTC PK
| 02/28/2017 | 11/30/2016 | 08/31/2016 | 05/31/2016 | 02/29/2016 | |
|---|---|---|---|---|---|
| Net Income | -1,100.20% | -2,093.37% | -268.82% | -627.80% | -895.42% |
| Total Depreciation and Amortization | 50.00% | 167.74% | 962.50% | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | -- | -- | -- |
| Change in Net Operating Assets | -160.81% | 2,954.55% | -1,214.29% | -198.10% | 76.19% |
| Cash from Operations | -96.35% | -225.12% | -278.11% | -1,149.67% | -1,157.66% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -185.32% | -184.64% | -78.76% | 616.67% | 3,532.23% |
| Total Debt Repaid | 100.00% | -6,300.00% | -- | -25.00% | -25.00% |
| Issuance of Common Stock | 358.44% | 358.44% | 358.44% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -100.00% | -99.20% | 60.16% | 385.75% | 8,843.48% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -182.93% | -166.40% | 395.47% | 2,525.22% | 7,969.05% |